Samsung Medison, a medical device company specializing in diagnostic imaging devices, has unveiled a new ultrasound system, HERA W10, powered by Beamforming technology.
Samsung Medison became an affiliate of Samsung Electronics in 2011 by integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.
The new generation of premium ultrasound system HERA W10 and prototype of a chair-type ultrasound system HERA I10 was unveiled at the 28th World Congress of the International Society of Ultrasound in Obstetrics & Gynecology (ISUOG) in Singapore.
HERA, which stands for Hyper-aperture Enhanced Reconstruction Architecture, features Samsung’s new Crystal Architecture to offer advanced technology and capabilities with a new level of image quality.
The new platform from Samsung integrates Crystal Architecture with an advanced transducer technology called S-Vue, enabling 11-fold increase in processing power and 10 times the data transfer speed compared to its previous system.
The new system can also be used for examining high-risk pregnancies and early diagnosis of abnormal fetus conditions.
Samsung Electronics Health & Medical Equipment President and Samsung Medison CEO Dongsoo Jun said: “Samsung is proud to introduce a new premium ultrasound system HERA W10 and a form factor innovation ultrasound HERA I10, as well as solutions that greatly improve the efficiency of hospitals.
“Samsung will continue to provide the best solutions possible and bring meaningful changes in the healthcare industry.”
Samsung stated that the Crystal Architecture offers a superior image with single crystal probe technology S-Vue, a new beamforming technology CrystalBeam and an advanced post-processing engine CrystalLive.
The ShadowHDR feature offers a shadow suppressed image, which is applicable to highly attenuated regions such as fetal head and spine.
The HQ-Vision feature allows for high resolution images to detect clinically important details.
The South Korean company also said that its new technology, MV-Flow, provides a detailed view of blood flow in relation to the surrounding tissues or pathology with an enhanced spatial and temporal resolution.
The LumiFlow feature provides a three-dimensional visualization of continuous and volumic vascular image.
In addition, the company has also showcased a prototype of HERA I10, which shares the same platform as HERA W10, but has been redesigned with new ergonomics.
The HERA I10 is claimed to address the discomfort caused by the spacing and the position of the clinicians and eliminates the need for the patient to shift their body, as it can be automatically adjusted for proper positioning.